Share
Market Research Report

ITALY PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug TypeLutetium (Lu-177)-based · and Yttrium (Y-90)-based
  • By IndicationGastroenteropancreatic Neuroendocrine Tumor · Foregut Neuroendocrine Tumor · Midgut Neuroendocrine Tumor · and Hindgut Neuroendocrine Tumor
  • By Distribution ChannelHospital Pharmacies and Retail Pharmacies
  • Published In04 Feb 2026
  • Report CodeCMI3139
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Market Segmentation

  • Drug Type Insights (Revenue, USD Mn, 2026 - 2033)

    • Lutetium (Lu-177)-based      
    • Yttrium (Y-90)-based

  • Indication Insights (Revenue, USD Mn, 2026 - 2033)

    • Gastroenteropancreatic Neuroendocrine Tumor
    • Foregut Neuroendocrine Tumor
    • Midgut Neuroendocrine Tumor
    • Hindgut Neuroendocrine Tumor

  • Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies